Related Experiment Videos
Roflamycoin--a new channel-forming antibiotic
Biochimica Et Biophysica Acta
|December 5, 1985
Summary
Roflamycoin, a new antifungal antibiotic, forms ion channels in sterol-containing lipid bilayers. These channels exhibit unique potential-dependent properties and high conductance, differing from amphotericin B channels.
Area of Science:
- Biophysics
- Membrane Biology
- Antimicrobial Research
Background:
- Lipid bilayers are crucial for cell function.
- Polyene antibiotics like amphotericin B form channels in sterol-containing membranes.
- Understanding novel channel-forming mechanisms is vital for drug development.
Purpose of the Study:
- To investigate the ion permeability properties of roflamycoin, a novel pentaene antibiotic.
- To compare the channel-forming mechanism of roflamycoin with amphotericin B.
- To elucidate the structural and functional differences in antibiotic-induced ion channels.
Main Methods:
- Electrophysiological studies of ion channel formation in lipid bilayers.
- Conductance measurements in varying salt concentrations.
- Analysis of channel lifetime and potential dependence.
Main Results:
- Roflamycoin increases membrane permeability in sterol-containing bilayers when applied to both sides.
- Roflamycoin channels are potential-dependent with short lifetimes (approx. 1 s) and high conductance (approx. 100 ps in 1 M KCl).
- Unlike amphotericin B channels, roflamycoin channels are not blocked by common blockers and exhibit linear conductance increase with salt concentration.
Conclusions:
- Roflamycoin and amphotericin B share a common channel formation mechanism involving semi-pores from antibiotic-sterol aggregates.
- Roflamycoin channels have a larger inner diameter due to a different antibiotic-to-sterol ratio, potentially influenced by its methyl group.
- Differences in terminal groups likely account for the distinct channel lifetimes between roflamycoin and amphotericin B.